Please assess the completion status of the following clinical trial:

Trial Title: Mifepristone Versus Misoprostol for Cervical Preparation Prior to Surgical Abortion Between 11 to 15 Weeks

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Age greater or equal to 18 years~* Fluency in English or Spanish~* Intrauterine pregnancy between 11 0/7 and 15 0/7 on the day of the abortion procedure~* Desire for pregnancy termination~* Ability to return for abortion procedure 24-48 hours after the preoperative visit~Exclusion Criteria:~* Allergy or contraindication to study agents~* Requirement of general anesthesia to perform the abortion~* Diagnosis of missed abortion, spontaneous abortion, incomplete abortion, or threatened abortion at time of initial preoperative evaluation

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- Mifepristone (Type: EXPERIMENTAL): Subjects will receive 200 mg of capsulized mifepristone orally for the purpose of cervical preparation before surgical abortion
- Misoprostol (Type: ACTIVE_COMPARATOR): Subjects will receive 400 mcg of buccal misoprostol for the purposes of cervical preparation.

Based on this trial design, predict the completion outcome and termination type (if applicable).